These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36992765)

  • 1. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey.
    O'Donnell S; Cooper D; Chen Y; Ballhausen H; Lewis DM; Froment T; Anna Gajewska K; Tappe A; Skinner T; Cleal B; Braune K
    Diabetes Res Clin Pract; 2023 Mar; 197():110235. PubMed ID: 36581143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences.
    Braune K; Krug N; Knoll C; Ballhausen H; Thieffry A; Chen Y; O'Donnell S; Raile K; Cleal B
    J Med Internet Res; 2022 Jul; 24(7):e37120. PubMed ID: 35834298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and psychological well-being among children and adolescents with diabetes and their caregivers using open-source automated insulin delivery systems: Findings from a multinational survey.
    Knoll C; Schipp J; O'Donnell S; Wäldchen M; Ballhausen H; Cleal B; Gajewska KA; Raile K; Skinner T; Braune K
    Diabetes Res Clin Pract; 2023 Feb; 196():110153. PubMed ID: 36423699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-source Web Portal for Managing Self-reported Data and Real-world Data Donation in Diabetes Research: Platform Feasibility Study.
    Cooper D; Ubben T; Knoll C; Ballhausen H; O'Donnell S; Braune K; Lewis D
    JMIR Diabetes; 2022 Mar; 7(1):e33213. PubMed ID: 35357312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital technologies as sources of information for patients and caregivers during COVID-19 pandemic: A cross-sectional survey.
    Hassan AYI; Bronzini M; Lamura G
    Digit Health; 2023; 9():20552076231156214. PubMed ID: 36908378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review.
    Kesavadev J; Srinivasan S; Saboo B; Krishna B M; Krishnan G
    Diabetes Ther; 2020 Jun; 11(6):1217-1235. PubMed ID: 32356245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.
    Braune K; O'Donnell S; Cleal B; Lewis D; Tappe A; Willaing I; Hauck B; Raile K
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14087. PubMed ID: 31364599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence on User-Led Innovation in Diabetes Technology (The OPEN Project): Protocol for a Mixed Methods Study.
    O'Donnell S; Lewis D; Marchante Fernández M; Wäldchen M; Cleal B; Skinner T; Raile K; Tappe A; Ubben T; Willaing I; Hauck B; Wolf S; Braune K
    JMIR Res Protoc; 2019 Nov; 8(11):e15368. PubMed ID: 31742563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes.
    Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M
    J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.
    Shahid A; Lewis DM
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians.
    Marshall DC; Holloway M; Korer M; Woodman J; Brackenridge A; Hussain S
    Diabetes Ther; 2019 Oct; 10(5):1553-1564. PubMed ID: 31440989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and Facilitators to Online Portal Use Among Patients and Caregivers in a Safety Net Health Care System: A Qualitative Study.
    Tieu L; Sarkar U; Schillinger D; Ralston JD; Ratanawongsa N; Pasick R; Lyles CR
    J Med Internet Res; 2015 Dec; 17(12):e275. PubMed ID: 26681155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
    Musolino G; Allen JM; Hartnell S; Wilinska ME; Tauschmann M; Boughton C; Campbell F; Denvir L; Trevelyan N; Wadwa P; DiMeglio L; Buckingham BA; Weinzimer S; Acerini CL; Hood K; Fox S; Kollman C; Sibayan J; Borgman S; Cheng P; Hovorka R
    BMJ Open; 2019 Jun; 9(6):e027856. PubMed ID: 31164368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-source automated insulin delivery systems and formal healthcare: A qualitative study of challenges in the interaction between service-users with type 1 diabetes and healthcare professionals.
    Raimond LH; O'Donnell S; Bøggild-Damkvist T; Filges T; Lomborg K
    Chronic Illn; 2023 Dec; 19(4):836-847. PubMed ID: 36437583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.